Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Rebecca Dent MD FRCP (Canada)
Chair, Divison of Medical Oncology & Senior Consultant, National Cancer Center Singapore
Professor, Duke-NUS Medical School, Singapore
Dr. Denise Wolf PhD
Senior Bioinformatics Scientist, Department of Laboratory Medicine, University of California, San Francisco, CA, USA
Luca Gianni MD
Michelangelo Foundation, Milano, Italy
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Dr. Iosifina Foskolou
Department of Haematopoiesis, Sanquin, Amsterdam, NL and
Department of Physiology, Development and Neuroscience, Cambridge University, UK
Prof. Pedro Romero MD
Deputy scientific managing director of the Lausanne Branch of the Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Switzerland
Prof. Laurence Zitvogel MD PhD
Gustave Roussy Comprehensive Cancer Institute, Villejuif, France
Université Paris Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France, INSERM U1015, Villejuif, France
Berna Özdemir MD PhD
Department of Medical Oncology, Bern University Hospital and University of Bern, Switzerland
Prof. Giuseppe Curigliano MD PhD
Associate Professor of Medical Oncology, University of Milano, Head of Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy
Prof. Dr. Niels Schaft PhD
Research group leader of the RNA-group, Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany